Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Acknowledgements Not applicable
Upregulates VEGF (Vascular Endothelial Growth Factor) BPC-157 increases VEGF expression, which drives angiogenesis the formation of new blood vessels at injury sites
Usually, a surfactant is added to the continuous-phase processing medium to prevent the microparticles from agglomerating and to control the size of the solvent microdroplets in the emulsion
What You Need For either format: Lyophilized peptide vial(s) separate retatrutide + cagrilintide, or one pre-mixed reta+cagri blend Bacteriostatic water (BAC water) sterile water with 0.9% benzyl alcohol preservative 30 mL syringe with 22-gauge needle for transferring BAC water 100-unit insulin syringes (U-100) for individual draws Alcohol swabs for vial-stopper sterilization Sharps container for used needles Clean flat surface with hands washed Pre-Mixed 12.5 / 2.5 mg Vial Reconstitution The 12.5/2.5 mg vial holds 15 mg total peptide (12.5 mg retatrutide + 2.5 mg cagrilintide) in a 5:1 mass ratio
Remove the protective caps from both vials
